ALEXAN, 50 MG/ML, ROZTWÓR DO INFUZJI, Liposomal Annamycin
MB-106
Phase 2 small_molecule active
Quick answer
ALEXAN, 50 MG/ML, ROZTWÓR DO INFUZJI, Liposomal Annamycin for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at Moleculin Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Moleculin Biotech
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active